scispace - formally typeset
E

Elliott M. Antman

Researcher at Brigham and Women's Hospital

Publications -  738
Citations -  187175

Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Blood oxygen measurements in the assessment of intracardiac left to right shunts: A critical appraisal of methodology

TL;DR: The curvilinear relation between systemic blood flow and oxygen step-up in determining the pulmonary to systemic flow ( Q P Q S ) ratio was expressed in a series of equations and depicted by a three dimensional surface.
Journal ArticleDOI

Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction

TL;DR: In patients with a LAD culprit lesion, proximal lesion location is a multivariate correlate of adverse outcomes even after adjustment for coronary blood flow and other covariates, which is likely due to a larger area of subtended myocardium.
Journal ArticleDOI

Workplace Wellness Recognition for Optimizing Workplace Health A Presidential Advisory From the American Heart Association

TL;DR: The American Heart Association/American Stroke Association will promote science-based best practices for comprehensive workplace wellness programs and establish benchmarks for a national workplace wellness recognition program to assist employers in applying the best systems and strategies for optimal programming.
Journal ArticleDOI

Rupture of the interventricular septum complicating acute myocardial infarction: a multicenter analysis of clinical findings and outcome

TL;DR: Analysis of clinical outcomes in 46 patients with ventricular septal rupture revealed that systolic blood pressure, right atrial pressure, and cardiopulmonary bypass time were strongly predictive of survival and identified a group of persons who wee much more likely to survive surgical intervention.
Journal ArticleDOI

Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.

TL;DR: Propafenone is a very promising agent for emergency intravenous therapy as well as long-term oral therapy in patients with Wolff-Parkinson-White syndrome and during electrophysiologic study, it caused a marked decrease in peak ventricular rate during atrial fibrillation.